Brandinium

Trademark search for:

LUYE PHARMA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2009-11-10 — Application filed
  • 2010-04-15 — Sn assigned for sect 66a appl from ib
  • 2010-04-16 — Limitation of goods/services from ib entered
  • 2010-04-19 — Application filed
  • 2010-04-19 — Assigned to examiner
  • 2010-04-23 — Application filed
  • 2010-04-26 — Final disposition recorded
  • 2010-04-27 — Office action issued
  • 2010-04-27 — Office action issued
  • 2010-04-27 — Office action issued
  • 2010-06-04 — Office action issued
  • 2010-09-17 — Teas/email correspondence entered
  • 2010-09-17 — Office action issued
  • 2010-09-17 — Correspondence received in law office
  • 2010-10-07 — Final disposition recorded
  • 2010-10-07 — Final disposition recorded
  • 2011-02-23 — Office action issued
  • 2011-03-07 — Assigned to lie
  • 2011-03-31 — Teas/email correspondence entered
  • 2011-03-31 — Correspondence received in law office
  • 2011-04-26 — Final disposition recorded
  • 2011-04-26 — Final disposition recorded
  • 2011-07-19 — Teas/email correspondence entered
  • 2011-07-19 — Office action issued
  • 2011-07-19 — Correspondence received in law office
  • 2011-08-08 — Final disposition recorded
  • 2011-08-09 — Final disposition recorded
  • 2011-09-21 — Notification of possible opposition sent to ib
  • 2011-09-21 — Notification of possible opposition created, to be sent to ib
  • 2011-12-29 — Teas/email correspondence entered
  • 2011-12-29 — Office action issued
  • 2011-12-29 — Correspondence received in law office
  • 2012-01-03 — Approved for pub - principal register
  • 2012-01-04 — Law office publication review completed
  • 2012-01-18 — Notice of publication
  • 2012-01-18 — Notification of possible opposition sent to ib
  • 2012-01-18 — Notice of start of opposition period created, to be sent to ib
  • 2012-02-07 — Published for opposition
  • 2012-02-11 — Notification processed by ib
  • 2012-04-24 — Registered-principal register
  • 2012-07-24 — Final disposition recorded
  • 2012-08-02 — Final disposition recorded
  • 2012-08-03 — Final disposition recorded
  • 2012-08-29 — Final disposition recorded
  • 2012-11-14 — Notification processed by ib
  • 2016-12-15 — Change of name/address rec'd from ib
  • 2018-10-18 — Teas section 71 received
  • 2018-11-15 — Case assigned to post registration paralegal
  • 2019-01-18 — Post registration action mailed - sec.71
  • 2019-03-14 — Office action issued
  • 2019-06-21 — New representative at ib received
  • 2019-08-12 — Registered-sec.71 accepted
  • 2019-08-12 — Notice of acceptance of sec. 71 - e-mailed
  • 2019-11-28 — International registration renewed
  • 2021-04-24 — Courtesy reminder - sec. 71 (10-yr) e-mailed
  • 2022-11-11 — Cancelled section 71
  • 2022-11-11 — Final status recorded
  • 2023-07-11 — Total invalidation of reg ext protection created
  • 2023-07-27 — Generic madrid transaction sent to ib
  • 2023-07-27 — Generic madrid transaction created
  • 2023-09-03 — Total invalidation processed by the ib

Owner Information

Shandong Luye Pharmaceutical Co., Ltd.
CN
Shandong Luye Pharmaceutical Co., Ltd.
CN
Shandong Luye Pharmaceutical Co., Ltd.
CN

Correspondent

MATTHEW D. ASBELL LADAS & PARRY LLP
1040 Avenue of the Americas
2T18705765
New York, NY 10018

Filing Details

Filing Date:
2009-11-10
Status Date:
2022-11-11
Category:
Pharmaceuticals
Filing Year:
2009

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.